Search

Your search keyword '"Casà A"' showing total 156 results
Start Over Author "Casà A" Publisher elsevier b.v.
156 results on '"Casà A"'

4. The HERMES calibration pipeline: mescal

Author

Dilillo, G., Marchesini, E.J., Della Casa, G., Baroni, G., Campana, R., Borciani, E., Srivastava, S., Trevisan, S., Ceraudo, F., Citossi, M., Evangelista, Y., Guzmán, A., Hedderman, P., Labanti, C., Virgilli, E., and Fiore, F.

Published
2024
Full Text
View/download PDF

18. Space applications of GAGG:Ce scintillators: a study of afterglow emission by proton irradiation

Author

Dilillo, Giuseppe, Zampa, Nicola, Campana, Riccardo, Fuschino, Fabio, Pauletta, Giovanni, Rashevskaya, Irina, Ambrosino, Filippo, Baruzzo, Marco, Cauz, Diego, Cirrincione, Daniela, Citossi, Marco, Casa, Giovanni Della, Di Ruzza, Benedetto, Evangelista, Yuri, Galgóczi, Gábor, Labanti, Claudio, Ripa, Jakub, Tommasino, Francesco, Verroi, Enrico, Fiore, Fabrizio, and Vacchi, Andrea

Published
2022
Full Text
View/download PDF

20. Advances in Multi-Variate Analysis Methods for New Physics Searches at the Large Hadron Collider

Author

Stakia, Anna, Dorigo, Tommaso, Banelli, Giovanni, Bortoletto, Daniela, Casa, Alessandro, de Castro, Pablo, Delaere, Christophe, Donini, Julien, Finos, Livio, Gallinaro, Michele, Giammanco, Andrea, Held, Alexander, Morales, Fabricio Jiménez, Kotkowski, Grzegorz, Liew, Seng Pei, Maltoni, Fabio, Menardi, Giovanna, Papavergou, Ioanna, Saggio, Alessia, Scarpa, Bruno, Strong, Giles C., Tosciri, Cecilia, Varela, João, Vischia, Pietro, and Weiler, Andreas

Published
2021
Full Text
View/download PDF

36. Safety and effectiveness of tofacitinib in ulcerative colitis: Data from TOFA-UC, a SN-IBD study.

Author

Macaluso, Fabio Salvatore, D'Antonio, Elvira, Fries, Walter, Viola, Anna, Ksissa, Omar, Cappello, Maria, Muscarella, Stefano, Belluardo, Nunzio, Giangreco, Emiliano, Mocciaro, Filippo, Di Mitri, Roberto, Ferracane, Concetta, Vitello, Alessandro, Grova, Mauro, Renna, Sara, Casà, Angelo, De Vivo, Simona, Ventimiglia, Marco, and Orlando, Ambrogio

Abstract

Real-world evidence is needed to determine the value of tofacitinib (TOFA) for the treatment of ulcerative colitis (UC). To assess the safety and effectiveness of TOFA in clinical practice. TOFA-UC is a multicenter, observational study performed among the Sicilian Network for Inflammatory Bowel Disease (SN-IBD). All consecutive patients with UC starting TOFA from its introduction in Sicily (July 2021) to July 2022 were included. 111 patients were included (mean follow-up: 31.7 ± 14.9 weeks; biologic-experienced: 92.8%). Nineteen adverse events were reported (17.1%; incidence rate: 28.2 per 100 patient years), including 11 cases of hypercholesterolemia and 3 infections (no cases of herpes zoster reactivation. At week 8, the rates of clinical response, steroid free clinical remission, and CRP normalization were 74.8%, 45.0%, and 56.9%, respectively, and 68.5%, 51.4%, and 65.2%, respectively, at the end of follow-up. Eighteen patients experienced a loss of response after successful induction (21.7%; incidence rate: 33.2 per 100 patient years). Twenty-six patients (23.4%) discontinued TOFA over time, of whom 3 due to AEs, and 23 to non response or loss of response. TOFA is safe and effective in patients with UC, including those with history of multiple failures to biological therapies. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

44. Sarcopenia is a negative predictive factor for endoscopic remission in patients with Crohn's disease treated with biologics.

Author

Grova, Mauro, Crispino, Federica, Maida, Marcello, Vitello, Alessandro, Renna, Sara, Casà, Angelo, Tesè, Lorenzo, Macaluso, Fabio Salvatore, and Orlando, Ambrogio

Abstract

Sarcopenia has been associated with poor prognosis in chronic diseases. To investigate the role of sarcopenia in predicting clinical and endoscopic outcomes in patients with Crohn's disease (CD). Consecutive CD patients who started biologics between 2014 and 2020 and underwent abdominal magnetic resonance or computed tomography within 6 months from the beginning of the biological therapy were enroled. Sarcopenia was defined as Psoas Muscle Index (PMI) lower than 5.4 cm²/m² (men) and 3.56 cm²/m² (women). Univariate and multivariate analyses were used to evaluate whether sarcopenia could predict steroid-free clinical remission (SFCR), endoscopic remission (ER), hospitalisation and surgery after 12 months of therapy. 358 patients were included. Sarcopenia was found in 18.2% of patients, and it was associated with a lower rate of ER (14.8% vs 47.7%; p = 0.002) after 12 months of therapy, while it was not associated with SFCR (65.1% vs 70.1%; p = 0.435), hospitalisation (9.2% vs 7.8%; p = 0.801) and surgery (3.1% vs 6.1%; p = 0.549). Sarcopenia was identified as a predictor of lack of ER (odds ratio [OR]=5.2; p = 0.006), as well as smoking (OR=2.5; p = 0.028) and perianal disease (OR=2.6; p = 0.020). Sarcopenia is a negative prognostic factor for ER in CD patients treated with biologics. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

46. Development of an app for estimating leaf area index using a smartphone. Trueness and precision determination and comparison with other indirect methods

Author

Confalonieri, R., Foi, M., Casa, R., Aquaro, S., Tona, E., Peterle, M., Boldini, A., De Carli, G., Ferrari, A., Finotto, G., Guarneri, T., Manzoni, V., Movedi, E., Nisoli, A., Paleari, L., Radici, I., Suardi, M., Veronesi, D., Bregaglio, S., Cappelli, G., Chiodini, M.E., Dominoni, P., Francone, C., Frasso, N., Stella, T., and Acutis, M.

Published
2013
Full Text
View/download PDF

50. 1302: From Blade To Beam: Unsheathing The Sabr After Prostatectomy

Author

Montero, Angel, Hernando, Ovidio, López, Mercedes, Valero, Jeannette, Ciérvide, Raquel, Chen-Zhao, Xin, Alvarez, Beatriz, de la Casa, Miguel-Angel, García-Aranda, Mariola, Sánchez, Emilio, Cañadillas, Carmen, Alonso, Rosa, García, Juan, Saiz, Carmen, Fernández-Letón, Pedro, and Rubio, Carmen

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results